Collectively, these results indicate that KISS1R signaling promotes tumor chemoresistance and pharmacological inhibition of KISS1R re-sensitizes cancer cells to doxorubicin, enabling them to undergo apoptosis. The gene discussed is KISS1R; the disease is neoplasm.